These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 4395651)

  • 21. Use of homozygous allogeneic bone marrow for induction of tolerance with antilymphocyte serum: dose and timing.
    Wood ML; Monaco AP; Gozzo JJ; Liegeois A
    Transplant Proc; 1971 Mar; 3(1):676-9. PubMed ID: 4398508
    [No Abstract]   [Full Text] [Related]  

  • 22. Immunologic protection of rabbit corneal allografts: preparation and in vitro testing of heterologous "blocking" antibody.
    Chandler JW; Gebhardt BM; Kaufman HE
    Invest Ophthalmol; 1973 Sep; 12(9):646-53. PubMed ID: 4582461
    [No Abstract]   [Full Text] [Related]  

  • 23. [Antilymphocyte serum (ALS) as immunosuppressive agent].
    Piardi W
    Folia Allergol (Roma); 1971; 18(1):27-68. PubMed ID: 4397372
    [No Abstract]   [Full Text] [Related]  

  • 24. [Our method for the production of antilymphocyte serum and the results of its experimental use].
    Metscharski St; Vasvasov N; Maimunkov K; Mozev D
    Z Exp Chir; 1972; 5(1):25-7. PubMed ID: 4156944
    [No Abstract]   [Full Text] [Related]  

  • 25. The effect of antilymphocyte serum on graft-versus-host reactivity.
    Haskovcová H; Nouza K
    Folia Biol (Praha); 1970; 16(6):391-6. PubMed ID: 4394680
    [No Abstract]   [Full Text] [Related]  

  • 26. Tolerance to skin allografts by immunosuppressive "pulse" of methylhydrazine derivatives and antilymphocyte serum.
    Floersheim GL; Brune K
    Transplant Proc; 1971 Mar; 3(1):688-92. PubMed ID: 4398510
    [No Abstract]   [Full Text] [Related]  

  • 27. Antilymphocytic serum--its constitution, effect and mode of action.
    James K
    Proc R Soc Med; 1970 Sep; 63(9):951-3. PubMed ID: 4991014
    [No Abstract]   [Full Text] [Related]  

  • 28. [Antilymphocyte serum in internal diseases].
    Teodorczyk J
    Pol Tyg Lek; 1971 Mar; 26(9):321-3. PubMed ID: 4101395
    [No Abstract]   [Full Text] [Related]  

  • 29. [Action of doxorubicin on immunogenesis].
    Shapovalova SP; Malkova IV
    Antibiotiki; 1983 Apr; 28(4):304-7. PubMed ID: 6344783
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Importance of the immunological enhancement for the survival time of a homologous graft].
    Benkö A
    Z Gesamte Inn Med; 1971 Jun; 26(11):345-52. PubMed ID: 4397958
    [No Abstract]   [Full Text] [Related]  

  • 31. [Present status of anti-lymphocyte serum and its problems].
    Fujimoto Y
    Geka Chiryo; 1969 Jul; 21(1):86-91. PubMed ID: 4901874
    [No Abstract]   [Full Text] [Related]  

  • 32. Modification of corneal homograft rejection by donor pretreatment with antilymphocyte serum.
    Lernor RE; Burde RM; Waltman SR
    Am J Ophthalmol; 1970 Mar; 69(3):453-7. PubMed ID: 4392176
    [No Abstract]   [Full Text] [Related]  

  • 33. Mode of action of antilymphocyte serum.
    Lance EM
    Fed Proc; 1970; 29(1):209-11. PubMed ID: 4904625
    [No Abstract]   [Full Text] [Related]  

  • 34. Synergism between cortisol and antilymphocyte serum. I. Observations in murine allograft systems.
    Gunn A; Lance EM; Medawar PB; Nehlsen SL
    Ciba Found Study Group; 1970; 36():66-72. PubMed ID: 4399436
    [No Abstract]   [Full Text] [Related]  

  • 35. A test to measure the immunosuppressive potency of antilymphocyte sera.
    Saleh WS; Gordon JJ; MacLean LD
    Surg Forum; 1969; 20():265-6. PubMed ID: 4392723
    [No Abstract]   [Full Text] [Related]  

  • 36. Use of low doses of homozygous allogeneic bone marrow cells to induce tolerance with antilymphocyte serum (ALS): tolerance by intraorgan injection.
    Monaco AP; Gozzo JJ; Wood ML; Liegeois A
    Transplant Proc; 1971 Mar; 3(1):680-3. PubMed ID: 4398509
    [No Abstract]   [Full Text] [Related]  

  • 37. [Graft-versus-host reactions: models, susceptibility to control, and clinical analogies].
    Brune K
    Schweiz Med Wochenschr; 1970 Jan; 100(2):49-58. PubMed ID: 4400853
    [No Abstract]   [Full Text] [Related]  

  • 38. Complications in prolonged administration of antilymphocytic sera.
    Koumans RK; Billote JB; Burke JF
    Transplant Proc; 1971 Mar; 3(1):807-10. PubMed ID: 4937973
    [No Abstract]   [Full Text] [Related]  

  • 39. Lymphocyte transfer factor.
    Thompson RB
    Rev Eur Etud Clin Biol; 1971 Mar; 16(3):201-4. PubMed ID: 4397550
    [No Abstract]   [Full Text] [Related]  

  • 40. The effect of heterologous antilymphocyte serum on the formation of H-2 antibody and the induction of allograft immunity.
    Monaco AP; Franco DJ
    Transplant Proc; 1969 Mar; 1(1):474-8. PubMed ID: 4944263
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.